Exelixis
EXEL
#1643
Rank
A$16.68 B
Marketcap
$58.44
Share price
-0.96%
Change (1 day)
69.88%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $79.51 AUD on 2000-07-26

Lowest end of day price: $2.08 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$53.97-0.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$81.91 0.00%๐Ÿ‡ซ๐Ÿ‡ท France
$158.08-2.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.87-0.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$439.29 0.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$237.37-0.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.46-0.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.31 3.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.22 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA